▽----MOMOSE-NET---- ●11/14 20:32 Mcl-1Pharmacokinetics and organ biodistribution are comparable to other radiometal-labeled antibodies, which have been evaluated in RIT clinical testsNovember 11, 2024 No CommentsPharmacokinetics and organ biodistribution are comparable to other radiometal-labeled antibodies, which have been evaluated in RIT clinical tests. the whole body. Tumor doses ranged from 24 to 172 cGy/mCi. Conclusion